Angiochem Se Voit Accorder Un Prêt Du Gouvernement Du Québec Afin De Conduire Son Essai Clinique De Phase III
04 juin 2019 07h00 HE
|
Angiochem
MONTRÉAL, 04 juin 2019 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) a annoncé aujourd’hui que le Gouvernement du Québec, par l’entremise du programme BioMed Propulsion, lui a accordé un...
Angiochem Receives Loan from Quebec Government to Perform Phase III Trial
04 juin 2019 07h00 HE
|
Angiochem
MONTREAL, June 04, 2019 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) announced today that it has been granted a $4 million loan from the Quebec Government through its BioMed Propulsion program....
Angiochem Announces Special Protocol Assessment (SPA) with US Food and Drug Administration (FDA)
06 août 2018 07h00 HE
|
Angiochem
MONTREAL, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special...